Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
The Russian community of geneticists, clinicians and bioethicists have reached a consensus on the use of genome-editing technologies on human embryos and germ cells for clinical purposes (see, for example, Nature574, 465–466; 2019). They consider that such experiments are premature at this point. Their view aligns with the position of the Russian ministry of health and sets the social context for further discussion of the technology.